In the News:
Objective Advises ANA Global in Sale to Gainline Capital Partners
READ HERE
About
Investment Banking
Business Services
Consumer
Healthcare Tech & Services
Life Science Services & Tech
Manufacturing & Distribution
Technology
M&A Clients
Valuation
Financial Reporting
Purchase Price Allocation (ASC 805)
Portfolio Company Valuations (ASC 820)
Goodwill Impairment (ASC 350)
Complex Financial Instruments (ASC 815)
Compensation (ASC 718)
Strategic Advisory
Business Buy/Sell Evaluation (BEV)
Transaction/Exit Planning
Strategic Decision Support
Litigation Planning
Financial Modeling & Deal Analysis
Business Planning & Pitchbook Preparation
Tax Advisory
IRC 409A Valuations
Estate & Gift
Corporate Restructuring
Fair Market Value
Intellectual Property
Transaction Opinions
ESOPs: Employee Stock Ownership Plans
Fairness Opinions
Recapitalization/Solvency Opinions
Valuation Clients
Content Hub
Resources
News & Announcements
Industry Reports
Podcasts
Advisor Resource Center
CONTACT US
About
Investment Banking
Business Services
Consumer
Healthcare Tech & Services
Life Science Services & Tech
Manufacturing & Distribution
Technology
M&A Clients
Valuation
Financial Reporting
Purchase Price Allocation (ASC 805)
Portfolio Company Valuations (ASC 820)
Goodwill Impairment (ASC 350)
Complex Financial Instruments (ASC 815)
Compensation (ASC 718)
Strategic Advisory
Business Buy/Sell Evaluation (BEV)
Transaction/Exit Planning
Strategic Decision Support
Litigation Planning
Financial Modeling & Deal Analysis
Business Planning & Pitchbook Preparation
Tax Advisory
IRC 409A Valuations
Estate & Gift
Corporate Restructuring
Fair Market Value
Intellectual Property
Transaction Opinions
ESOPs: Employee Stock Ownership Plans
Fairness Opinions
Recapitalization/Solvency Opinions
Valuation Clients
Content Hub
Resources
News & Announcements
Industry Reports
Podcasts
Advisor Resource Center
CONTACT US
Transaction
Mabvax Therapeutics Holdings, Inc.
BioNTech · 2018
